reference/1892631

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1892631

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	735
issn	0390-6078 1592-8721
issueIdentifier	4
pageRange	728-735
publicationName	Haematologica
startingPage	728
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_69731bb36a4061fbaf74a48f03dfbd8c
bibliographicCitation	Ades L, Prebet T, Stamatoullas A, Recher C, Guieze R, Raffoux E, Bouabdallah K, Hunault M, Wattel E, Stalnikiewicz L, Toma A, Dombret H, Vey N, Sebert M, Gardin C, Chaffaut C, Chevret S, Fenaux P. Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies. Haematologica. 2016 Dec 29;102(4):728–35. doi: 10.3324/haematol.2016.151894.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa01a740952ec7f05f86d2ed3b45890b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a2210ad8245a8d4265ba0260daf5547 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7027-040X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be2bc124c991778fd37edbdc99959810 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23c7c87c46770a95f75d98c1d682d2a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_545e569bf5ec7b8248a0e7cff34f08f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c468f1ea7afec1ff1afb8728b2ccd951 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2af331fc9439bad2183195eb4c782898 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a48b9167179227cf6853ee4663dba11 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04f0ae63c6dbab73c97e5d4e82a9fed3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7053506d0e926fc576dccc20f4f509ca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26949a5d936f8c483ab8eefa4a3871e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7777-5216 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef3364542bedaacef158ac3fe8ac2124 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ee53ae0867e93f0878227d6397cd696 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05213e7801bd23bc7832e779c517f7a4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e00e228dc8a26554954f071016b19a4a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55bb414ee14a3587ab5bcd6a85792238 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e3179f231c04d028aaa704e66094f2b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6449-4730 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ff2f578299671b047dcc829a898220f
date	2016-12-29^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC5395113 https://pubmed.ncbi.nlm.nih.gov/28034993 https://doi.org/10.3324/haematol.2016.151894
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3942 https://portal.issn.org/resource/ISSN/0390-6078 https://portal.issn.org/resource/ISSN/1592-8721
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies
discusses	http://id.nlm.nih.gov/mesh/M0479831 http://id.nlm.nih.gov/mesh/M0021267
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009190Q000235 http://id.nlm.nih.gov/mesh/D009190Q000188 http://id.nlm.nih.gov/mesh/D002895 http://id.nlm.nih.gov/mesh/D015470Q000188 http://id.nlm.nih.gov/mesh/D015470Q000235 http://id.nlm.nih.gov/mesh/D002872 http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D009190Q000401 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000077269 http://id.nlm.nih.gov/mesh/D015470Q000401 http://id.nlm.nih.gov/mesh/D009190Q000175 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D015470Q000175 http://id.nlm.nih.gov/mesh/D013792Q000031 http://id.nlm.nih.gov/mesh/D013792Q000008 http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_08107456d8bcd45da877127a55a55980 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8560 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216326 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6253 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7277

Showing number of triples: 1 to 75 of 75.